UGHANMWAN EFEOVBOKHAN: Open Payments
NPI 1649387630 · WINDCREST, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 20 payments from 9 companies in 2025. Trend: 2023 $866 · 2024 $704 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $200 |
| SHIELD THERAPEUTICS INC | 4 | $74 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Stimlabs LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: AUSTEDO XR, ACCRUFER, INVEGA SUSTENNA, REXULTI, MOUNJARO, FREESTYLE LIBRE 3, ALLACOR P, COBENFY.
Industry payments across TX — which companies pay providers there.
